NewsBenzinga라이프코어 바이오메디컬, 3분기 주당순손실 1.08달러로 예상치 0.28달러 하회, 매출 2,532만 2천 달러로 예상치 2,669만 9천 달러 하회 라이프코어 바이오메디컬, 3분기 주당순손실 1.08달러로 예상치 0.28달러 하회, 매출 2,532만 2천 달러로 예상치 2,669만 9천 달러 하회 Benzinga 2026.11.04 12:24 (GMT+0) Open on Benzinga Other news Wedbush Maintains Outperform on Spyre Therapeutics, Lowers Price Target to $120 Autolus Therapeutics To Present Clinical Update Abstracts At American Society of Hematology Meeting, December 12-15 Wedbush Maintains Neutral on Ultragenyx Pharmaceutical, Lowers Price Target to $22 Magic Empire Global Secures $100M Facility From Anyu International To Finance Its Timber Supply Chain Trading Operations Wedbush Maintains Outperform on Denali Therapeutics, Raises Price Target to $24 Conference call: Stanley Black & Decker Sees FY 2026 Sales expected to be flat YoY
Autolus Therapeutics To Present Clinical Update Abstracts At American Society of Hematology Meeting, December 12-15
Magic Empire Global Secures $100M Facility From Anyu International To Finance Its Timber Supply Chain Trading Operations
